Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide (E/C/F/TAF)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide (E/C/F/TAF), covering 2020-08-07 to 2020-08-07. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide as a First-line Treatment in Naïve Patients With HIV-1 Infection With Severe Immunosuppression [Phase 4]